文献速递胃肠外科围术期管理与 ERAS

机器人辅助与胸腔镜食管切除术的远期肿瘤学与功能结局比较

Robot-assisted versus thoracoscopic esophagectomy for esophageal cancer: long-term oncological and functional outcomes.
PubMed 文献 · Surg Endosc · 2026-03-05

该回顾性研究纳入2018至2022年639例胸段食管癌切除术患者,经倾向性评分匹配后比较122对机器人辅助食管切除术(RE)与胸腔镜食管切除术(TE)。RE组失血量更少、炎症反应更低、ICU住院更短,3年总生存率更高(78.1% vs 68.1%,p=0.01),但多因素分析未证实OS差异独立。

要点

  • RE与更少失血、更低炎症反应和更短ICU住院相关,并发症率与TE相当。
  • 匹配队列中RE的3年OS高于TE(78.1% vs 68.1%,p=0.01),RFS相似。
  • RE组术后4个月FEV1下降幅度小于TE(-3.6% vs -8.4%,p=0.004)。

核心结论

  • RE与更好的围术期恢复和早期功能保留相关,但多因素分析未证实OS差异独立。

研究设计与样本

  • 回顾性队列研究,2018至2022年639例胸段食管癌切除术患者,倾向性评分匹配后122对。

主要发现

  • 匹配队列中RE组失血量更少、炎症反应更低、ICU住院更短,并发症率与TE相当。
  • RE组3年OS为78.1%,TE组为68.1%(p=0.01),cStage III亚组分别为71.8%和57.5%(p=0.044),RFS相似。
  • 单因素分析显示TE、pT>3、pStage>III和淋巴血管侵犯为不良预后因素,多因素分析仅pStage>III为独立预测因子(HR 5.20,95%CI 2.54-10.40,p<0.001)。
  • RE组骨骼肌指数(SMI)保持在肌少症阈值7 kg/m2以上,TE组持续低于阈值,但无统计学差异。
  • RE组术后4个月FEV1下降幅度小于TE(-3.6% vs -8.4%,p=0.004);按早期FEV1下降分层的生存分析中,RE低下降组3年OS为81.8%,TE高下降组为58.5%(p=0.005)。

临床怎么用

  • RE可考虑用于胸段食管癌切除术,以改善围术期恢复和早期肺功能保留。
  • 术后早期FEV1下降幅度可能有助于风险分层,但需进一步验证。

局限性

  • 回顾性设计,存在选择偏倚可能。
  • OS差异在多因素分析中未证实独立。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Robot-assisted esophagectomy (RE) has been increasingly adopted as an alternative to thoracoscopic esophagectomy (TE) for esophageal cancer. While RE has shown perioperative advantages, its long-term oncological and functional outcomes remain unclear. This study compared short- and long-term outcomes, as well as postoperative changes in body composition and pulmonary function. METHODS: We retrospectively reviewed 639 patients who underwent esophagectomy for thoracic esophageal cancer between 2018 and 2022. After excluding non-standard procedures, 205 underwent RE and 434 TE. Propensity score matching was performed based on demographic, nutritional, functional, and oncological factors, yielding 122 matched pairs. Surgical outcomes, complications, overall survival (OS), relapse-free survival (RFS), skeletal muscle index (SMI), and pulmonary function (FEV1) were compared. RESULTS: In the matched cohort, RE was associated with reduced blood loss, lower inflammatory response, and shorter ICU stay, with comparable complication rates to TE. The 3-year OS was higher in RE than TE (78.1% vs 68.1%, p = 0.01), particularly in cStage III (71.8% vs 57.5%, p = 0.044), whereas RFS was similar. Univariate analysis identified TE, pT > 3, pStage > III, and lymphovascular invasion as adverse prognostic factors, while multivariate analysis confirmed pStage > III as the only independent predictor (HR 5.20, 95% CI 2.54-10.40, p < 0.001). SMI remained above the sarcopenia threshold (7 kg/m2) in RE but consistently below in TE, despite no statistical difference. The decline in FEV1 at 4 months was smaller in RE (-3.6% vs -8.4%, p = 0.004). Survival analysis stratified by early FEV1 decline (ΔFEV) showed superior outcomes in patients with preserved function, with the RE ΔFEV low group showing the most favorable prognosis compared with the TE ΔFEV high group (3-year OS: 81.8% vs 58.5%, p = 0.005). CONCLUSIONS: RE was associated with improved perioperative recovery and early functional preservation compared with TE. The observed differences in OS were not confirmed in multivariable analysis.

来源:Surg Endosc,查看原文。版权归原作者所有。

引用

  1. Ishiyama K, Nozaki R, Kakuta R, et al. Robot-assisted versus thoracoscopic esophagectomy for esophageal cancer: long-term oncological and functional outcomes. Surg Endosc. 2026. PMID: 41787079. doi:10.1007/s00464-026-12697-6

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。